February 18, 2014
Daiichi Sankyo and UMN Pharma announced on February 14 that the two companies have entered into a joint research agreement for norovirus vaccine. With the agreement, Daiichi Sankyo will receive antigen manufactured by UMN Pharma. Under the terms of the...read more